Another central pathway involving increased neuropeptide Y (NPY) arising from leptin resistance during obesity is implicated in bone metabolism as mice with increased central NPY have concurrent obesity with bone loss (49) and NPY deficiency in ob/ob mice leads to improved cortical bone mass (50). Here, NPY is linked to obesity due to melanocortin 4 receptor deficiency.